The rating affirmation is based on a number of factors, including Baystate’s strong market share and position as a key teaching hospital and high-acuity services in western Massachusetts.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Baystate will improve its financial performance in fiscal year 2016.
More articles on healthcare finance:
Tenet posts unexpected $59M loss in Q1
OIG tags Louisiana hospital for incorrect billing
Backed by 15 major healthcare players, Heritage Group closes $220M fund
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
